Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Although the deleterious vasoconstrictive effects of cell-free, hemoglobin-based blood substitutes have been appreciated, the systemic effects of chronic hemolysis on nitric oxide bioavailability have not been considered or quantified. Central to this investigation is the understanding that nitric oxide reacts at least 1,000 times more rapidly with free hemoglobin solutions than with erythrocytes. We hypothesized that decompartmentalization of hemoglobin into plasma would divert nitric oxide from homeostatic vascular function. We demonstrate here that plasma from patients with sickle-cell disease contains cell-free ferrous hemoglobin, which stoichiometrically consumes micromolar quantities of nitric oxide and abrogates forearm blood flow responses to nitric oxide donor infusions. Therapies that inactivate plasma hemoglobin by oxidation or nitric oxide ligation restore nitric oxide bioavailability. Decompartmentalization of hemoglobin and subsequent dioxygenation of nitric oxide may explain the vascular complications shared by acute and chronic hemolytic disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Priapism, nephropathy, and sickle vasculopathy are associated with hemolysis.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“In these complications HbF has a less obvious beneficial effect, perhaps because only a small number of lysed sickle erythrocytes are needed to trigger these subphenotypes.59”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“As HbF falls and fewer F-cells are protected from HbS polymer damage, the propensity for vascular occlusion and intravascular hemolysis increases with the release of heme products into the circulation that scavenge nitric oxide causing endothelial damage and vasculopathy.[57][58][59]”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“A further consequence of sickling of cells is increased RBC hemolysis. Hemolysis affects not only the number of circulating RBCs but also release of Hb (and other cytoplasmic proteins) within the blood stream, thus profoundly affecting the viscosity and colloid properties of plasma and increasing systemic NO scavenging (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
In the citing paper
“For example, in hemolytic anemia, release of free Hb may lead to systemic NO scavenging, affecting vascular tone (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
Citations
Cites
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Mechanism of NO-induced oxidation of myoglobin and hemoglobin
Eich, R. F., Li, T., Lemon, D. D., Doherty, D. H., Curry, S. R., Aitken, J. F., Mathews, A. J., Johnson, K. A., Smith, R. D., Phillips, et al. (1996) · Biochemistry · doi:10.1021/bi960442g · Cited by 613
Diffusion-limited reaction of free nitric oxide with erythrocytes
Liu, X., Miller, M. J. S., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., & Lancaster, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18709 · Cited by 512
A Tutorial on the Diffusibility and Reactivity of Free Nitric Oxide
Lancaster, J. R. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0112 · Cited by 495
Nitric oxide in the human respiratory cycle
McMahon, T. J., Moon, R. E., Luschinger, B. P., Carraway, M. S., Stone, A. E., Stolp, B. W., Gow, A. J., Pawloski, J. R., Watke, P., Singel, D. J., et al. (2002) · Nature Medicine · doi:10.1038/nm718 · Cited by 469
Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11482 · Cited by 441
Self-citationRate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
Doherty, D. H., Doyle, M. P., Curry, S. R., Vali, R. J., Fattor, T. J., Olson, J. S., & Lemon, D. D. (1998) · Nature Biotechnology · doi:10.1038/nbt0798-672 · Cited by 432
Autoxidation kinetics of aqueous nitric oxide
Ford, P. C., Wink, D. A., & Stanbury, D. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81748-o · Cited by 419
Research works printed but not linked: 3
- Vaughn, M.W., Kuo, L. & Liao, J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 274, H1705–H1714 (1998).
- Vogel, W.M., Dennis, R.C., Cassidy, G., Apstein, C.S. & Valeri, C.R. Coronary constrictor effect of stroma-free hemoglobin solutions. Am. J. Physiol. 251, H413–H420 (1986).
- Pohl, U. & Lamontagne, D. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide. Basic Res. Cardiol. 86, 97–105 (1991).
Cited by
Items 801–900 of 1,000
Intracranial stenting as monotherapy in subarachnoid hemorrhage and sickle cell disease
Ediriwickrema, A., Williamson, T. L., Hebert, R. M., Matouk, C. C., Johnson, M. H., & Bulsara, K. R. (2012) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2011-010224 · Cited by 16
“Additionally, released hemoglobin binds to nitric oxide resulting in microvascular dysfunction.(16) Hemoglobin polymerization is considered a causative factor for intravascular hemolysis, endothelial dysfunction, red blood cell (RBC) membrane changes, vaso-occlusion, and inflammatory and hypercoagulable states.”
BackgroundAdvances in the management of sickle cell disease
Thompson, A. A. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20630 · Cited by 14
“Elevated plasma arginase correlates with the rate of hemolysis, suggesting that the enhanced red cell turnover in sickle cell disease leads to dysregulated arginine metabolism [50,51].”
BackgroundSickle Cell Disease at the Dawn of the Molecular Era
Abboud, M. R., & Musallam, K. M. (2009) · Hemoglobin · doi:10.3109/03630260903347617 · Cited by 14
“Nitric Oxide Hemolytic anaemia remains the driving force behind many complications of SCD because of its effects on NO bioavailability (17).”
BackgroundDahan, I., Farber, E., Thauho, N., Nakhoul, N., Francis, A., Awawde, M., Levy, A. P., Kim‐Shapiro, D. B., Basu, S., & Nakhoul, F. M. (2015) · Journal of Diabetes Research · doi:10.1155/2015/613860 · Cited by 15
Upadhya, B., Stacey, R. B., Ntim, W. O., Knovich, M. A., & Pu, M. (2014) · Acta Haematologica · doi:10.1159/000357393 · Cited by 13
Role of TCD in sickle cell disease: A review
Zétola, V. D. H. F. (2012) · Perspectives in Medicine · doi:10.1016/j.permed.2012.03.016 · Cited by 17
Wijnsma, K. L., Veissi, S. T., de Wijs, S., van der Velden, T. J. A. M., Volokhina, E. B., Wagener, F. A. D. T. G., van de Kar, N. C. A. J., & van den Heuvel, L. P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.547406 · Cited by 13
Carr, J. M. J. R., Ainslie, P. N., MacLeod, D. B., Tremblay, J. C., Nowak‐Flück, D., Howe, C. A., Stembridge, M. R., Patrician, A., Coombs, G. B., Stacey, B. S., et al. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221119442 · Cited by 13
Matos, C. F. D., Comont, T., Castex, M., Lafaurie, M., Walter, O., Moulis, G., Dion, J., & Cougoul, P. (2022) · Expert Review of Hematology · doi:10.1080/17474086.2022.2149488 · Cited by 14
“Nitric oxide (NO), a powerful vasodilator, is catabolized to inactive nitrates by interaction with cell-free oxyhemoglobin [13,14].”
BackgroundIn search of the optimal iron chelation therapy for patients with thalassemia major
Berdoukas, V. A., & Wood, J. C. (2010) · Haematologica · doi:10.3324/haematol.2010.034397 · Cited by 13
Pulmonary hypertension in children with sickle cell disease
Zuckerman, W. A., & Rosenzweig, E. B. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.6 · Cited by 13
McFarlane, I. M., Ozeri, D. J., Saperstein, Y., Álvarez, M. R., Leon, S. Z., Koci, K., Francis, S., Singh, S., & Salifu, M. O. (2017) · Rheumatology Current Research · doi:10.4172/2161-1149.1000225 · Cited by 13
“This leads to decreased bioavailability of NO and decreased vasodilation producing a paradoxical compensatory increase of NO expression in tissues despite endothelial dysfunction [51].”
BackgroundGretchen, C., Bayir, H., Kochanek, P. M., Ruppert, K. M., Viegas, M., Palmer, D., & Kim‐Campbell, N. (2021) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002814 · Cited by 15
“org February 2022 • Volume 23 • Number 2 PHb levels in studies of extracorporeal therapies, such as CPB or extracorporeal life support (ECLS), are higher (2, 3) than the levels found in sickle cell anemia that increase vascular resistance and reduce blood flow (4).”
Blood feud: Keeping hemoglobin from nixing NO
Liao, J. C. (2002) · Nature Medicine · doi:10.1038/nm1202-1350 · Cited by 13
An update on arginine in sickle cell disease
Benites, B. D., & Saad, S. T. O. (2019) · Expert Review of Hematology · doi:10.1080/17474086.2019.1591948 · Cited by 14
Smani, Y., Faivre, B., Audonnet, S., Labrude, P., & Vigneron, C. (2005) · European Surgical Research · doi:10.1159/000083141 · Cited by 13
EDITORIAL: Red blood cell hemolysis: an old standard in changing times
Heaton, W. A. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02495.x · Cited by 13
The vaso-occlusive pain crisis in sickle cell patients: A focus on pathogenesis
Javaherforooshzadeh, F., Fateh, A., Saffari, H., Khodadadi, M., Samarin, M. E., Nikoubakht, N., Dadgar, F., & Goodarzi, V. (2025) · Current Research in Translational Medicine · doi:10.1016/j.retram.2025.103512 · Cited by 18
Red blood cell extracellular vesicles: new frontiers in hematological biomarker discovery
Joshi, U., George, L.-B., & Highland, H. N. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1644077 · Cited by 12
Clinical relevance of pulmonary vasculature involvement in sickle cell disease
Carstens, G. R., de Araújo-Paulino, B. B., Katayama, E. H., Amato‐Lourenço, L. F., Fonsêca, G. H. H., Souza, R., Aiello, V. D., & Mauad, T. (2019) · British Journal of Haematology · doi:10.1111/bjh.15795 · Cited by 12
“The occlusive pulmonary vasculopathy is importantly dependent on mechanisms linked to the presence of cell-free plasma haemoglobin, which reacts irreversibly with nitric oxide (NO), inhibiting NO signalling and producing vasoconstriction (Reiter et al, 2002).”
BackgroundHeme Burden and Ensuing Mechanisms That Protect the Kidney: Insights from Bench and Bedside
Balla, J., & Zarjou, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158174 · Cited by 12
“These effects are likely due to offsetting the vasoconstriction associated with nitric oxide depletion [130].”
BackgroundThangaswamy, S., Branch, C. A., Ambadipudi, K., & Acharya, S. A. (2021) · Biomolecules · doi:10.3390/biom11101473 · Cited by 13
“Though plasma of SCD patients has been shown to contain free ferrous hemoglobin and its scavenging of increased quantities of NO [36,37], NY1DD mice are essentially free of hemolysis and the hypoxia-induced impairment of hemodynamics is mainly from ischemic reperfusion injuries.”
BackgroundPinheiro, A. K., Pereira, D. A., dos Santos, J. L., Calmasini, F. B., Alexandre, E. C., Reis, L. O., Burnett, A. L. “., Costa, F. F., & Silva, F. H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269310 · Cited by 12
“However, in SCD, high concentrations of hemoglobin are released into the plasma, saturating haptoglobin, and thus accumulating free hemoglobin in the plasma [35, 36].”
BackgroundOxidized hemoglobin triggers polyreactivity and autoreactivity of human IgG via transfer of heme
Planchais, C., Noé, R., Gilbert, M., Lecerf, M., Kaveri, S. V., Lacroix‐Desmazes, S., Roumenina, L. T., & Dimitrov, J. D. (2023) · Communications Biology · doi:10.1038/s42003-023-04535-5 · Cited by 13
“The spectra of 0.5 μM of metHb alone or of 0.5 μM metHb in the presence of: (1) 2 μM hemopexin; (2) 2 mM KCN; (3) 2 mM KCN and 2 μM hemopexin, and (4) 2 μM holo-hemopexin (prepared by pre-incubation of 50 μM hemopexin with 50 μM hematin for 5 min) were recorded in wavelength range 350–700 nm with data acquisition spee…”
MethodInfluentialCharacterization of exercise-induced hemolysis in endurance horses
Pakula, P. D., Halama, A., Al-Dous, E. K., Johnson, S. J., Filho, S. A., Suhre, K., & Vinardell, T. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1115776 · Cited by 12
“Hb also decreases nitric oxide (NO) bioavailability, critical for smooth muscle tone regulation, platelet activation, and aggregation modulation (26, 27).”
BackgroundAsthma Management in Sickle Cell Disease
Gomez, E., & Morris, C. R. (2013) · BioMed Research International · doi:10.1155/2013/604140 · Cited by 13
“Despite an increase inNOS, NO bioavailability is low due to low substrate availability [53], NO scavenging by cell-free hemoglobin released during hemolysis [85], and through reactions with free radicals such as superoxide and other reactive NO species [86–88].”
BackgroundRaval, J. S., Wearden, P. D., Orr, R. A., & Kiss, J. E. (2012) · Journal of Clinical Apheresis · doi:10.1002/jca.21236 · Cited by 12
The Impact of Surgery and Stored Red Blood Cell Transfusions on Nitric Oxide Homeostasis
Nagababu, E., Scott, A. V., Johnson, D. J., Goyal, A., Lipsitz, J. A., Barodka, V. M., Berkowitz, D. E., & Frank, S. M. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001392 · Cited by 13
Investigation of Lipid Profile and Clinical Manifestations in SCA Children
da Guarda, C. C., Yahouédéhou, S. C. M. A., Santiago, R. P., Fernandes, C. F. D. L., Neres, J. S. D. S., Oliveira, A. M. D. J., Aleluia, M. M., Figueiredo, C. V. B., Fonseca, C. A., Fiuza, L. M., et al. (2020) · Disease Markers · doi:10.1155/2020/8842362 · Cited by 14
“cell survival [38] and intravascular hemolysis [7], which creates a prooxidant and proinflammatory vascular milieu that contributes to endothelial dysfunction [39].”
BackgroundContinuous Inhaled Nitric Oxide Therapy in a Case of Sickle Cell Disease with Multiorgan Involvement
Chang, W.-L., Corate, L. M., Sinclair, J. M., & van der Heyde, H. C. (2008) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31818cb612 · Cited by 12
Bailey, D. M., Culcasi, M., Filipponi, T., Brugniaux, J. V., Stacey, B. S., Marley, C. J., Soria, R., Rimoldi, S. F., Černý, D., Rexhaj, E., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.028 · Cited by 14
“These outcompete reaction with intra-erythrocytic Hb by ~1000-fold [64], reducing rates of S -nitro- sothiol formation and/or deoxyHb-mediated reduction of NO (cid:0) 2 to NO, stable (i.e. RBC-encapsulated) metabolites that conserve/transfer bioactivity within the hypoxic microcirculation.”
Endothelial Dysfunction in Acute Hepatic Porphyrias
Ricci, A., Sandri, G., Marcacci, M., Pierro, E. D., Granata, F., Cuoghi, C., Marchini, S., Pietrangelo, A., & Ventura, P. (2022) · Diagnostics · doi:10.3390/diagnostics12061303 · Cited by 12
“Interestingly, the neuronal populations of the myenteric plexus express NOSs [44]: an impairment of NO metabolism in these tissues has been proposed as a cause of gastrointestinal dysautonomias in conditions such as sickle-cell disease [45] or paroxysmal nocturnal hemoglobinuria [46].”
BackgroundThe Evolving Landscape of Drug Therapies for Sickle Cell Disease
Rai, P., Desai, P. C., & Ataga, K. I. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.06.008 · Cited by 14
Moyamoya syndrome in sickle cell anaemia: a cause of recurrent stroke
Soares, D., Bullock, R., & Ali, S. B. (2014) · BMJ Case Reports · doi:10.1136/bcr-2014-203727 · Cited by 12
“37 Imaging fi ndings in our patient were very interesting.”
Evidence for a Novel Mechanism Independent of Myocardial Iron in β-Thalassemia Cardiac Pathogenesis
Stoyanova, É., Cloutier, G., Felfly, H., Lemsaddek, W., Ah-Son, N., & Trudel, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052128 · Cited by 15
Barcelos, G. R. M., de Marco, K. C., Rezende, V. B., Braga, G. Ú. L., Antunes, L. M. G., Tanus-Santos, J. E., & Barbosa, F. (2015) · Archives of Environmental Contamination and Toxicology · doi:10.1007/s00244-015-0137-8 · Cited by 12
Self-citationShilo, N. R., & Morris, C. R. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1364989 · Cited by 13
“Free hemoglobin released into the plasma from lysed erythrocytes directly scavenges NO [43,48].”
BackgroundInfluentialNew viruses shake old paradigms
Wang, C., & Sugden, B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420662 · Cited by 14
Lockamy, V. L., Shields, H. W., Kim‐Shapiro, D. B., & KING, S. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.07.003 · Cited by 12
Donadee, C., & Gladwin, M. T. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.061 · Cited by 14
“In these studies, the vasoconstrictive ffects of NO depletion caused by hemolysis could be ounteracted by inhaled NO, which reacts directly with the ell-free Hb in the pulmonary circulation, oxidizing it to ethemoglobin, which cannot then scavenge the NO sysemically (2,10).”
BackgroundSelf-citationWallen, G. R., Middleton, K. R., Kazmi, N. B., Yang, L., & Brooks, A. T. (2021) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2021/5539004 · Cited by 11
“In addition, studies show that the hemoglobin released from intravascular hemolysis scavenges nitric oxide from blood plasma [2], leading to recurrent vasoocclusive crises that are usually accompanied by disabling pain.”
BackgroundEnd Organ Affection in Sickle Cell Disease
Bathla, T., Lotfollahzadeh, S., Quisel, M. J., Mehta, M., Malikova, M. A., & Chitalia, V. C. (2024) · Cells · doi:10.3390/cells13110934 · Cited by 13
“The authors found that the patients with SCD have higher levels of the thrombin–antithrombin complex, prothrombin fragment F1+2, D-dimer, and endothelial soluble vascular endothelial cell adhesion molecule (sVCAM) activation as compared to control subjects.”
BackgroundAntioxidants, Radical Scavengers, and Their Impact on Oxidative Stress
Ohiagu, F. O., Chikezie, P. C., Maduka, T. O., Chikezie, C. M., Nwaiwu, O., & Paudel, K. R. (2025) · Free Radicals and Antioxidants · doi:10.5530/fra.2024.2.7 · Cited by 16
Crosstalk Between Sickle Cell Disease and Ferroptosis
Russo, A., Patanè, G. T., Calderaro, A., Barreca, D., Tellone, E., & Putaggio, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083675 · Cited by 12
“Reiter et al. instead observed that MetHb, present in plasma in high concentrations in cases of SCD, can interact with NO, leading to the production of methemoglobin nitrate and iron-nitrosemoglobin complexes, which reduce the plasma concentration of NO, favoring vasoconstriction [44,45].”
InfluentialThompson, P. A., Chew, E., & Szer, J. (2013) · Internal Medicine Journal · doi:10.1111/imj.12268 · Cited by 11
PPARγ increases HUWE1 to attenuate NF-κB/p65 and sickle cell disease with pulmonary hypertension
Jang, A. J., Chang, S. S., Park, C., Lee, C., Benza, R. L., Passineau, M. J., Ma, J., Archer, D. R., Sutliff, R. L., Hart, C. M., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002754 · Cited by 11
The different facets of sickle cell disease-related pulmonary hypertension
Prohaska, C. C., & Machado, R. F. (2021) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000795 · Cited by 11
Iacopucci, A. P. M., Pereira, P. D. S., Pereira, D. A., Calmasini, F. B., Pittalà, V., Reis, L. O., Burnett, A. L. “., Costa, F. F., & Silva, F. H. (2022) · The FASEB Journal · doi:10.1096/fj.202200867r · Cited by 11
Gillespie, M. L., Spring, M. R., Cohen, R. T., & Klings, E. S. (2022) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2022.101602 · Cited by 13
Transport of nitric oxide by perfluorocarbon emulsion
Ortiz, D., Cabrales, P., & Briceño, J. C. (2013) · Biotechnology Progress · doi:10.1002/btpr.1797 · Cited by 11
“However, NOs ability to be transported by blood is limited by NO reactions with oxygen, including NO dioxygenation reaction with oxyhemoglobin (oxy-Hb), which forms nitrate (NO3 (2), inert) and methemoglobin (met-Hb).(6) In vitro, the reaction rate in aqueous solutions of NO with oxygen and Hb follows a secondorder ki…”
BackgroundGladwin, M. T. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.66 · Cited by 11
Self-citationOxidative alterations in sickle cell disease: Possible involvement in disease pathogenesis
Öztaş, Y., & Yalçınkaya, A. S. (2017) · World Journal of Hematology · doi:10.5315/wjh.v6.i3.55 · Cited by 11
Pathobiology of Sickle Cell Disease
Hebbel, R. P., & Vercellotti, G. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00041-x · Cited by 11
Inhaled Nitric Oxide for Treatment of Sickle Cell Stroke
Montero-Huerta, P., HESS, D. R., & Head, C. A. (2006) · Anesthesiology · doi:10.1097/00000542-200609000-00028 · Cited by 11
The McConnell Sign is Seen in Patients With Acute Chest Syndrome
McCutcheon, J. B., Schafer, P. E., Lyon, M. L., & Gordon, R. D. (2018) · Journal of Ultrasound in Medicine · doi:10.1002/jum.14585 · Cited by 11
The effects of hydroxycarbamide on the plasma proteome of children with sickle cell anaemia
Brewin, J. N., Tewari, S., Menzel, S., Kirkham, F. J., Inusa, B. P. D., Renney, G., Ward, M. A., & Rees, D. C. (2019) · British Journal of Haematology · doi:10.1111/bjh.15996 · Cited by 11
“This study demonstrated three ways in which HC may be beneficial in SCA, and iden- tified novel proteins that may be useful to monitor therapeutic response.”
BackgroundInfluentialHemolysis-mediated Toxicity during Cardiopulmonary Bypass Ameliorated by Inhaled Nitric Oxide Gas
Satoh, T., Xu, Q., Wang, L., & Gladwin, M. T. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1165ed · Cited by 12
Self-citationTargeting heme in sickle cell disease: new perspectives on priapism treatment
Silveira, T. H. R., Calmasini, F. B., de Oliveira, M. G., Costa, F. F., & Silva, F. H. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1435220 · Cited by 10
Stark, M., Wang, A. Y., Corrigan, B., Woldu, H. G., Azizighannad, S., Cipolla, G., Kocharian, R., & León, H. D. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102668 · Cited by 10
“The cytosolic content of ORC-mediated RBC lysis, comprised mainly of hemoglobin, is released to the local environment, where it limits the availability of nitric oxide, prevents vasodilation, and promotes platelet adhesion [39 – 41].”
Starlard‐Davenport, A., Palani, C. D., Zhu, X., & Pace, B. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094192 · Cited by 10
“This toxic process contributes to cardiac dysfunction, leading to cardiomyopathy, heart failure, and pulmonary hypertension because of repeated injury to cells [64–67], among other complications.”
Changes in Heme Levels During Acute Vaso-occlusive Crisis in Sickle Cell Anemia
Cardoso, E. C., Silva-Neto, P. V. D., Hounkpe, B. W., Chénou, F., Albuquerque, C. C. M. X., Garcia, N. P., Silva-Junior, A. L., Malheiro, A., Cesar, P., de Lima, F., et al. (2021) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2021.08.002 · Cited by 11
dos Santos, A. F., Almeida, C. B., Brugnerotto, A. F., Roversi, F. M., Pallis, F. R., Franco‐Penteado, C. F., Lanaro, C., de Albuquerque, D. M., Leonardo, F. C., Costa, F. F., et al. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.08.021 · Cited by 10
Echocardiographic evaluation of thalassemia intermedia patients in Duhok, Iraq
Mohammad, A. M. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-183 · Cited by 10
“Following the release of hemoglobin into plasma, the plasma hemoglobin can scavenge nitric oxide as well as catalyze the formation of reactive oxygen and nitrogen species, the processes that can lead to acute and chronic pulmonary vasoconstriction [20].”
Backgroundde Haan, J. J., Windsant, I. C. V., Lubbers, T., Hanssen, S. J., Hadfoune, M., Prinzen, F. W., Greve, J.-W. M., & Buurman, W. A. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828e9262 · Cited by 10
Karafin, M. S., Carpenter, E. L., Pan, A. Y., Simpson, P. M., & Field, J. J. (2017) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2017.01.008 · Cited by 11
Oxidized Hemoglobin Is Antigenic and Immunogenic in Lupus
Jain, S., Bose, A., Bastia, B., Sharma, H., Sachdeva, R., Jain, A. K., & Pal, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00732 · Cited by 10
Ikechukwu, E. L., Okafor, P. N., & Egba, S. I. (2020) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-020-00512-y · Cited by 10
Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndrome
Jutant, E., Voiriot, G., Labbé, V., Savale, L., Mokrani, H., Dreden, P. V., Gerotziafas, G., & Fartoukh, M. S. (2021) · ERJ Open Research · doi:10.1183/23120541.00496-2021 · Cited by 11
Tellier, E., Widemann, A., Cauchois, R., Faccini, J., Lagarde, M., Brun, M., Robert, P., Robert, S., Bachelier, R., Poullin, P., et al. (2022) · Haematologica · doi:10.3324/haematol.2022.280651 · Cited by 10
“We also observed high free heme concentrations in iTTP plasma, in the order of magnitude of those observed in sickle cell disease and HUS patients.(24,25) Heme induced VWF exocytosis and participated in iTTP-induced Ca-mediated EC activation since VWF exocytosis was 30%-decreased by hemopexin.”
Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin
Chiang, K. C., Gupta, A., Sundd, P., & Krishnamurti, L. (2023) · Biomedicines · doi:10.3390/biomedicines11020338 · Cited by 11
Gotardo, É. M. F., de Brito, P. L., Gushiken, L. F. S., Chweih, H., Leonardo, F. C., Costa, F. F., & Conran, N. (2023) · Vascular Pharmacology · doi:10.1016/j.vph.2023.107176 · Cited by 10
Laboratory Methods for Diagnosis and Evaluation of Hemoglobin Disorders
Steinberg, M. H., Fabry, M. E., & Old, J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.038 · Cited by 13
High levels of neopterin and interleukin-3 in sickle cell disease patients
Rodrigues, L. P., Costa, F. F., Saad, S. T. O., & Grotto, H. Z. W. (2006) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20104 · Cited by 10
“It has been demonstrated that during intravascular hemolysis, the physical separation of hemoglobin from endothelium is disrupted, resulting in efficient nitric oxide scavenging and endothelial dysfunction (20).”
BackgroundSaleemi, S. (2014) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.134039 · Cited by 13
“In reality, PH in hemolytic disorders is mainly a combination of precapillary and postcapillary PH and while a small proportion of patients have hypoxia-induced PH and thromboembolic PH, as shown in Figure 2.[19,45-49]”
BackgroundDecrease in lung nitric oxide production after peritonitis in mice with sickle cell disease*
Bartolucci, P., Ngo, M., Beuzard, Y., Galactéros, F., Saber, G., Rideau, D., Eddahibi, S., Maître, B., Adnot, S., & Delclaux, C. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000253403.65602.ea · Cited by 10
“NO scavenging by cell-free hemoglobin related to hemolysis could have been an alternative hypothesis (6), but we were unable to show any difference in plasma LDH concentration in SAD and littermate animals after peritonitis.”
BackgroundDeonikar, P., & Kavdia, M. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01173.2011 · Cited by 11
Pecker, L. H., & Ackerman, H. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_7 · Cited by 11
Severe Hemolysis and Pulmonary Hypertension in a Neonate With Upshaw–Schulman Syndrome
Tsujii, N., Shiraishi, I., Kokame, K., Shima, M., Fujimura, Y., Takahashi, Y., & Matsumoto, M. (2016) · PEDIATRICS · doi:10.1542/peds.2016-1565 · Cited by 10
Silva, M., Vargas, S., Coelho, A., Ferreira, E., Mendonça, J., Vieira, L., Maia, R., Dias, A., Ferreira, T., Morais, A., et al. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102436 · Cited by 12
Cheung, Y. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-11851-7.00006-9 · Cited by 10
Level of nitric oxide and antioxidant vitamins in sickle cell anaemia patients.
Hundekar, P. S., Suryakar, A. N., Karnik, A., Katkam, R., Joshi, N. G., & Ghone, R. A. (2012) · PubMed · Cited by 10
Recent trends in pulmonary arterial hypertension
Natarajan, R. (2011) · Lung India · doi:10.4103/0970-2113.76300 · Cited by 12
“[18] The destruction of nitric oxide by free hemoglobin and increased production of reactive oxygen species seem important in the development of PAH.[19-21]”
BackgroundAnalysis of nitric oxide donor effectiveness in resistance vessels
Hyduke, D. R., & Liao, J. C. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00990.2004 · Cited by 10
Lin, E. E., Gladwin, M. T., & Machado, R. F. (2005) · PubMed · Cited by 10
Self-citationFogarty, H., Ahmad, A., Atiq, F., Doherty, D., Ward, S. E., Karampini, E., Rehill, A. M., León, G., Byrne, C., Geoghegan, R., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010824 · Cited by 10
Ramde-Tien, A., Tibiri, A., Ouédraogo, M., ., S. O., ., O. G. N., & ., I. P. G. (2014) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2014.829.835 · Cited by 9
Sousa‐Santos, O., Neto‐Neves, E. M., Ferraz, K. C., Sertorio, J. T. C., Portella, R. L., & Tanus-Santos, J. E. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.09.014 · Cited by 9
Self-citationInflammation and Sickle Cell Anemia
Almeida, C. B., Kato, G. J., & Conran, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_8 · Cited by 9
Wang, A., Singh, S., Yu, B., Bloch, D. B., Zapol, W. M., & Kluger, R. (2018) · Transfusion · doi:10.1111/trf.15003 · Cited by 9
Sickle cell disease in the era of precision medicine: looking to the future
Steinberg, M. H., Kumar, S. S., Murphy, G. J., & Vanuytsel, K. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1688658 · Cited by 9
Pethő, D., Gáll, T., Hendrik, Z., Nagy, A., Beke, L., Gergely, A. P., Méhes, G., Tóth, C., Gram, M., Åkerström, B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136668 · Cited by 9
“The ferrous form of the heme group has been described to react with nitric-oxide, reducing its vasodilator effect and leading to vasoconstriction, hypertension and MetHb formation [21].”
BackgroundDony, C., Illipparambil, L. C., Maeda, T., Mroczek, S., Rovitelli, A., Wexler, O., Malnoske, M., Bice, T., Fe, A. Z., Storms, C. R., et al. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000006006 · Cited by 9
“In contrast, the plasma NOC in critically ill patients is considerably lower than reported after RBC transfusion, hemodialysis, cardiopulmonary bypass, and in sickle cell anemia (9–12 , 36).”
BackgroundResultInfluentialSterile inflammation induces vasculopathy and chronic lung injury in murine sickle cell disease
Rarick, K. R., Li, K., Teng, R., Jing, X., Martin, D. P., Xu, H., Jones, D. W., Hogg, N., Hillery, C. A., Garcia, G. J. M., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.052 · Cited by 11
Self-citationAssessment of Endothelial Dysfunction in Health and Disease; Using Various Parameters
Jalali, M., & Phadke, M. S. (2011) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-011-0140-4 · Cited by 9
“scavenging and endothelial dysfunction [5, 6].”
Acute myocardial infarction in hemoglobin SC disease
Wang, H. E., Laslett, L. J., Richman, C. M., & Wun, T. (2004) · Annals of Hematology · doi:10.1007/s00277-004-0907-2 · Cited by 9
“Hemolysis in SCD results in increased concentration of free hemoglobin in the plasma, which consumes nitric oxide and may lead to vasoconstriction [ 13 ].”
BackgroundMorris, C. R. (2010) · The Open Nitric Oxide Journal · doi:10.2174/1875042701002020041 · Cited by 10
“Under normal conditions, hemoglobin is safely packaged within the erythrocyte plasma membrane, however during hemolysis it is decompartmentalized and released into plasma where it rapidly reacts with and destroys NO [43].”
BackgroundSickle cell disease in the ICU
Cecchini, J., & Fartoukh, M. S. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000258 · Cited by 10
“Finally and despite a strong physiologic rationale [4], trials on the use of inhaled NO, as compared with supplemental oxygen, did not demonstrate any improvement in painful VOC [60] or ACS [61 & ] courses.”
BackgroundLeg Ulceration in Sickle Cell Disease: An Early and Visible Sign of End‐Organ Disease
Singh, A. P., & Minniti, C. P. (2016) · InTech eBooks · doi:10.5772/64234 · Cited by 11
“This free hemoglobin scavenges NO, reducing its bioavailability and thus linked to hemolysis‐vascular dysfunction syndrome which is charac‐ terized by chronic vasoconstriction contributing to leg ulcers, priapism, and pulmonary hypertension [19, 20].”
BackgroundAssessment of some indicators of oxidative stress in nigerian sickle cell anemic patients
Nwagha, T. U., Okorie, C., & Ejezie, F. E. (2018) · Annals of African Medicine · doi:10.4103/aam.aam_26_17 · Cited by 9
“[21] After hemolysis, hemoglobin is compartmentalized and released into plasma, where it rapidly reacts with NO which destroys it.[22] This results in the abnormally increased consumption of NO forming NO free radicals and ultimately inhibiting vasodilation.”
BackgroundDas, D., Tarafdar, P. K., & Chakrabarti, A. (2018) · FEBS Letters · doi:10.1002/1873-3468.13165 · Cited by 9
Metadata
- Authors
- Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T.
- Affiliations
- National Institutes of Health (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Gladwin, Mark T.
- Venue
- Nature Medicine
- Published
- 2002-11-11
- Volume
- 8
- Issue
- 12
- Pages
- 1383-1389
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4241694836
- Semantic Scholar
- 80bbf9611dbe14c7276b2a4dbca6e42007866746
- Cited by
- 1,330
- References
- 45
- Citations by year
- 2026: 44 · 2025: 39 · 2024: 45 · 2023: 39 · 2022: 57 · 2021: 55 · 2020: 56 · 2019: 59 · 2018: 60 · 2017: 45 · 2016: 62 · 2015: 63 · 2014: 69 · 2013: 68 · 2012: 68
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM55792)
- National Center for Research Resources (P41RR001008, RR 01008)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- free hemoglobin, nitric oxide bioavailability, sickle cell disease, chronic hemolysis, plasma hemoglobin, forearm blood flow, hemoglobin oxidation, vasoconstriction
- MeSH terms
- Adult, Anemia, Sickle Cell, Biological Availability, Heme, Hemocyanins, Hemoglobins, Hemolysis, Humans, Middle Aged, Nitric Oxide, Oxidation-Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.